Detalhe da pesquisa
1.
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo.
Blood
; 122(7): 1192-202, 2013 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23770777
2.
Tumor rejection in Cblb-/- mice depends on IL-9 and Th9 cells.
J Immunother Cancer
; 9(7)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34272310
3.
JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.
Mol Cell Endocrinol
; 451: 88-96, 2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28131742
4.
Get a grip on immune cells by inhibiting JAKs.
Oncoimmunology
; 5(2): e1071009, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27057437